Fagron completes share buy-back program
20 9월 2023 - 1:08AM
Fagron completes share buy-back program
Regulated informationNazareth (Belgium)/Rotterdam (The
Netherlands), 19 September 2023 – 6PM CET
Fagron completes share buy-back
program
Fagron has successfully completed its share buy-back program
today. In the last period, from 18 September 2023 through 19
September 2023, Fagron purchased 17,266 of its owns shares at an
average price of €16.12 per share corresponding to a total amount
of €277,612.81.
A total of 138,372 Fagron shares have been repurchased under the
buy-back program at an average price of €16.31 per share,
corresponding to a total amount of €2,256,826.89.
The share buy-back program was announced on 3 August 2023. The
repurchased shares will be used to fulfill Fagron’s obligations
under its long term incentive scheme.
More information, including a detailed overview of the purchase
transactions under this program, is available on our share buy-back
webpage.
Further
informationKaren BergGlobal
Investor Relations ManagerTel. +31 6 53 44 91
99karen.berg@fagron.com
About FagronFagron is a
leading global company active in pharmaceutical compounding,
focusing on delivering personalized medicine to hospitals,
pharmacies, clinics and patients in more than 30 countries around
the world.
Belgian company Fagron NV has its registered office in Nazareth
and is listed on Euronext Brussels and Euronext Amsterdam under the
ticker symbol ‘FAGR’. Fagron’s operational activities are managed
by the Dutch company Fagron BV, which is headquartered in
Rotterdam.
In the event of differences between the English translation and
the Dutch original of this press release, the latter prevails.
- Fagron completes share buy back program
Fagron NV (EU:FAGR)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Fagron NV (EU:FAGR)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024
